NCT06994819Completed
Evaluation of the Niostem Headset for Hair Growth and Hair Quality
Double-blind Randomized Controlled Clinical Trial Under Dermatological Monitoring on Skin Tolerability and Efficacy of the Niostem Headset on Hair Growth, Hair Loss and Hair Quality After 3 and 6 Months of Daily Use
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Completed
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- Mane Biotech GmbH
- Participants (registry)
- 101
- Start
- October 2023
- Primary completion
- September 2024
- Study completion
- September 2024
- Last registry update
- June 2025
- Countries
- Germany
Conditions studied: Androgenetic Alopecia, Pattern Baldness
Interventions: niostem headset (Active), Sham niostem headset (Placebo)
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.